Skip to content
DraconiticResearch
Search Sources API
203,234 studies31 sourcesUpdated 22 min ago
Peer-reviewedCC BY 4.0PLOS One

The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico

  1. 1Division of Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico
  2. 2Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico
  3. 3Auxiliary Secretariat for Public Health Surveillance & Protection, Puerto Rico Department of Health, San Juan, Puerto Rico

Abstract

Background: Breast cancer is the most common cancer among women globally. Early detection using mammography is crucial for improving outcomes and reducing aggressive treatment. Factors such as age, comorbidities, insurance coverage, and mental health conditions may influence screening behavior. Limited research exists on the relationship between mental health and breast cancer screening in Puerto Rico. This study examines factors associated with early detection among women aged 50 and older diagnosed with breast cancer and coexisting anxiety or affective disorder. Methods: We conducted a retrospective cohort study using data from the Puerto Rico Central Cancer Registry linked with the Health Insurance Linkage Database. Multivariable logistic regression was used to estimate adjusted odds ratios (AOR) to describe the relationship between having anxiety or affective disorder with the use of mammography and the stage at diagnosis. Cox proportional hazards model was used to assess the association between mental health diagnosis and risk of death, respectively. Results: Among 4,708 eligible women, 376 (8.0%) had an anxiety or affective disorder. Overall, 90.0% received a mammogram within 24 months prior to diagnosis, and 35.1% were diagnosed at a late stage. Women with anxiety or affective disorder were 57.0% more likely to have undergone screening (AOR 1.57, 95% confidence interval [CI]: 1.01–2.43; p = 0.046). These disorders were not significantly associated with cancer stage at diagnosis (AOR 0.86, 95% CI 0.68–1.09; p = 0.208) and did not increase the risk of death within 5 years (Adjusted Hazard Ratio [AHR] 1.01, 95% CI: 0.76–1.35; p = 0.094). Conclusion: In our study, anxiety or affective disorders were associated with increased mammography use but not with earlier cancer stages. Further research is needed on severe mental illness and the bidirectional relationship between cancer and mental health.

Related

  1. The impact of negative life events on adolescents and young adults affective disorders: a moderated mediation analysis
    Youshan Ma, Fuling Wan, Jinglong Wu +8
    BMC PsychiatryPeer-reviewedCC BY-NC-ND 4.0Full textPsychiatry & mental healthPMC
  2. A Retrospective Study Analysing the Outcomes of Anxiety, Depression, and Sleep Disorders in Post-Chemotherapy Patients With Breast Cancer Based on Symptom-Targeted Supportive Psychological Nursing
    Yanyan Shi, Yu Zhou, Jin Yan +3
    Actas Españolas de PsiquiatríaPeer-reviewedCC BY 4.0Full textOncologyPMC
  3. Disparities in screening participation and stage at diagnosis for breast and bowel cancers among individuals with pre-existing mental health disorders: A population-based study
    Yueh-Hsin Wang, Ajay Aggarwal, Elizabeth A. Davies
    PLOS OnePeer-reviewedCC BY 4.0Full textEpidemiology & public healthOncologyPLOSPMC
  4. The impact of cancer-related workplace discrimination on anxiety among breast cancer survivors
    K Ntobeng, G Ruiz-de-Azua, I Licaj +7
    The European Journal of Public HealthPeer-reviewedCC BY-NC 4.0Full textOncologyPMCEurope PMC
  5. Impact of remote management using patient-reported outcomes on pain and anxiety after breast biopsy: the BIO-PSY randomized controlled trial.
    Estelle Guerdoux, Louise Coutant, Anas Al Herk +8
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerPeer-reviewedCC BY-NC-NDFull textOncologyEurope PMC
BibTeX
@article{vazquezroldan2026impact,
  title = {{The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico}},
  author = {Marjorie Vázquez-Roldán and Karen J. Ortiz-Ortiz and Liza I. Millán-Pérez and Axel Gierbolini-Bermúdez and Ruth Ríos-Motta},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0357375},
  url = {https://doi.org/10.1371/journal.pone.0357375},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - The impact of anxiety and affective disorders on breast cancer screening in women in Puerto Rico
AU  - Marjorie Vázquez-Roldán
AU  - Karen J. Ortiz-Ortiz
AU  - Liza I. Millán-Pérez
AU  - Axel Gierbolini-Bermúdez
AU  - Ruth Ríos-Motta
PY  - 2026
DA  - 2026/09/11
JO  - PLOS One
DO  - 10.1371/journal.pone.0357375
UR  - https://doi.org/10.1371/journal.pone.0357375
AB  - Background: Breast cancer is the most common cancer among women globally. Early detection using mammography is crucial for improving outcomes and reducing aggressive treatment. Factors such as age, comorbidities, insurance coverage, and mental health conditions may influence screening behavior. Limited research exists on the relationship between mental health and breast cancer screening in Puerto Rico. This study examines factors associated with early detection among women aged 50 and older diagnosed with breast cancer and coexisting anxiety or affective disorder. Methods: We conducted a retrospective cohort study using data from the Puerto Rico Central Cancer Registry linked with the Health Insurance Linkage Database. Multivariable logistic regression was used to estimate adjusted odds ratios (AOR) to describe the relationship between having anxiety or affective disorder with the use of mammography and the stage at diagnosis. Cox proportional hazards model was used to assess the association between mental health diagnosis and risk of death, respectively. Results: Among 4,708 eligible women, 376 (8.0%) had an anxiety or affective disorder. Overall, 90.0% received a mammogram within 24 months prior to diagnosis, and 35.1% were diagnosed at a late stage. Women with anxiety or affective disorder were 57.0% more likely to have undergone screening (AOR 1.57, 95% confidence interval [CI]: 1.01–2.43; p = 0.046). These disorders were not significantly associated with cancer stage at diagnosis (AOR 0.86, 95% CI 0.68–1.09; p = 0.208) and did not increase the risk of death within 5 years (Adjusted Hazard Ratio [AHR] 1.01, 95% CI: 0.76–1.35; p = 0.094). Conclusion: In our study, anxiety or affective disorders were associated with increased mammography use but not with earlier cancer stages. Further research is needed on severe mental illness and the bidirectional relationship between cancer and mental health.
SN  - 1932-6203
ER  -